|

LECS Combined With LSNNS for Early Gastric Cancer (LENS Trial)

RECRUITINGSponsored by Peking University People's Hospital
Actively Recruiting
SponsorPeking University People's Hospital
Started2026-08-04
Est. completion2028-12-31
Eligibility
Age20 Years – 80 Years
Healthy vol.Accepted

Summary

Early gastric cancer (EGC) is traditionally treated with either endoscopic resection or standard laparoscopic gastrectomy with formal lymph node dissection. However, endoscopic resection cannot evaluate or treat regional lymph node metastasis, whereas standard surgery significantly impairs postoperative gastric physiological function and patient quality of life (QoL). The LENS trial is a prospective, single-arm clinical study designed to evaluate the feasibility, safety, and long-term efficacy of Laparoscopic and Endoscopic Cooperative Surgery (LECS) combined with Laparoscopic Sentinel Node Navigation Surgery (LSNNS) using Indocyanine Green (ICG) fluorescence tracing for patients with cT1N0M0 early gastric cancer. In this trial, eligible patients will undergo intraoperative sentinel lymph node (SN) biopsy guided by ICG. Patients with negative SN status will receive stomach-preserving surgery (primarily Non-exposed Endoscopic Wall-inversion Surgery, NEWS), while those with positive SN status will convert to standard laparoscopic gastrectomy. The primary goal is to confirm whether this combined procedure provides long-term oncological safety comparable to standard radical gastrectomy, while significantly improving postoperative gastric function, nutritional status, and quality of life.

Eligibility

Age: 20 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Preoperative biopsy confirming solitary lesion of gastric adenocarcinoma
* Preoperative magnifying endoscopy diagnosis of differentiated T1b (\> 3 cm) or undifferentiated T1b
* Scheduled to undergo laparoscopic surgery
* Age between 20 and 80 years
* ECOG performance status of 0 or 1
* Signed written informed consent to participate in this clinical study

Exclusion Criteria:

* Suitable for endoscopic treatment (e.g., standard ESD indications)
* Unsuitable for surgery due to severe comorbidities (such as severe cardiopulmonary diseases)
* Pregnant women
* Known history of allergy to Indocyanine Green (ICG)
* Prior history of upper abdominal surgery (except laparoscopic cholecystectomy)
* Prior history of upper abdominal radiation therapy
* Coexistence of other malignant tumors within the past 5 years

Conditions2

CancerEarly Gastric Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.